Divial

Quick links to important sections

Divial

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Divial

Property Description
Active ingredient Lorazepam
Form Tablets, Oral Solution, Injectable Solution
Pharmacological class Benzodiazepine, CNS Depressant
General purpose Relieves acute mental tension and agitation
Origin Synthetic Compound

Divial is a pharmaceutical product containing the active ingredient Lorazepam, fundamentally classified as a Benzodiazepine derivative, which is a powerful class of synthetic medications designed to modulate the central nervous system (CNS). Divial is a single-ingredient product, confirming that its therapeutic effect is solely attributed to the international nonproprietary name (INN) substance, Lorazepam.

What Type of Medicine is Divial?

Divial belongs to the Benzodiazepine pharmacological class, functioning primarily as an anxiolytic and sedative-hypnotic agent. The substance Lorazepam is a known chemical entity used to provide rapid relief from acute central nervous system overactivity and is clinically recognized for its short-to-intermediate duration of action, differentiating it from very long-acting benzodiazepines. The medication is supplied in multiple dosage forms, including tablets for standard oral consumption and an injectable solution provided in ampoules for parenteral (intravenous or intramuscular) administration.

Lorazepam's Role and General Purpose

The general purpose of Lorazepam is to induce profound physiological and mental calm by acting as a strong CNS depressant. It is recognized as a potent, fast-acting agent used to stabilize acute states of high tension and agitation. By specifically enhancing the effects of the brain's main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), Lorazepam effectively slows down excessive neural communication. This mechanism translates into a general therapeutic role centered on reducing over-excitation, promoting sedation, and relieving associated symptoms such as pronounced mental restlessness and elevated muscle tension.

Regulatory References

  1. Label: LORAZEPAM tablet - DailyMed - NIH

What side effects are possible with Divial?

Adverse Reactions and Safety Characteristics

The official safety documentation for Lorazepam (the active ingredient in Divial) classifies adverse reactions based on their frequency and the system-organ class affected, with a primary focus on effects related to its central nervous system (CNS) depressant activity.


Regulatory Safety Summary

Classification Common Adverse Reactions (CNS)
Very Common / Common Sedation, somnolence (drowsiness), ataxia (lack of coordination), dizziness, fatigue, and muscle weakness.
Uncommon Nausea, blurred vision, change in libido, and minor skin reactions.

Serious Adverse Reactions

Regulatory agencies have documented risks of serious, life-threatening outcomes, which include Respiratory Depression, especially when used in conjunction with other CNS depressants such as opioids. A major regulatory concern is the potential for developing physical and psychological dependence, with the risks increasing with higher doses and longer duration of use. Anterograde amnesia (impaired memory after use) and rare paradoxical reactions (e.g., agitation, aggression) are also documented.

Population-Specific Safety Considerations

The official labeling notes that older adults are generally more susceptible to the sedative effects, increasing the risk of dizziness, unsteadiness, and falls. Caution is required for patients with compromised respiratory function (due to the risk of depression) and those with severe hepatic insufficiency, as the medicine may worsen conditions like hepatic encephalopathy. Common CNS effects are more likely to occur at the start of treatment and may lessen with continued use, while the risk of dependence increases with exposure time.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope

Authoritative medical information indicates that an overdose with any prescription medicine, including Divial, is a serious medical emergency that can result in profound toxicity. The severity is typically classified by the resulting physiological effects and their threat to vital functions. Documented overdose presentations commonly involve significant central nervous system and cardiorespiratory depression, but specific manifestations are dependent on the compound's class and dose.

Classification Area Official Regulatory Context (General)
Severity Classification Ranging from mild to severe, including life-threatening events (e.g., coma or death).
Physiological Systems Affected Typically includes the nervous, respiratory, and cardiovascular systems.
Exposure-related Factors Overdose risk is associated with the intake of a dose significantly exceeding the prescribed amount, or co-ingestion with other central nervous system depressants.

When Immediate Medical Help is Required

Urgent medical attention is required immediately upon the recognition of any potential overdose or the onset of severe, uncharacteristic symptoms following ingestion of the medicine. These may include, but are not limited to, severe drowsiness, confusion, loss of consciousness, or difficulty breathing (respiratory depression). Emergency actions must focus on supportive care for vital functions, which may involve respiratory support or other appropriate treatments as determined by medical professionals. Never attempt to treat a suspected overdose without emergency medical supervision.

Therapeutic Uses of Divial

Divial, containing lorazepam, is commonly used across conditions presenting with acute episodes, offering supportive relief when symptoms become temporarily overwhelming. Its applications focus on managing symptoms related to heightened distress and neurological activity.

Easing Acute Anxiety and Tension

The medication is applied in contexts where additional symptomatic support is needed for managing symptoms related to psychological and physical tension, such as those that accompany episodes of pronounced anxiety. It helps address symptom clusters that may appear suddenly, providing support that helps ease the overall symptom burden and contributes to easing the overall symptom load.

Stabilization in Crisis and Procedural Contexts

Divial is commonly used in situations involving recurrent or episodic manifestations, such as when symptoms of increased neurological activity require symptomatic management (e.g., status epilepticus). It is also relevant when supportive symptom management is appropriate for managing severe behavioral agitation. It is applied during phases where symptoms become more noticeable, such as before a medical procedure (preoperative sedation), where it contributes to easing the overall symptom load and helps reduce memory of the immediate procedure.


Quick Fact: Support for Heightened Symptoms
Applied in situations where symptoms of psychological tension, severe agitation, or neurological overactivity require short-term symptomatic assistance.

Regulatory References

  1. MedlinePlus Drug Information overview on Lorazepam

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Divalproex Sodium — official regulatory information

This section outlines the eligibility and exclusion criteria as documented in authoritative government regulatory sources (e.g., FDA, EMA) for the medicine, Divalproex Sodium.


Eligibility scope

Populations for whom use is contraindicated:

  • Patients with hepatic disease or significant hepatic dysfunction.
  • Patients with known urea cycle disorders.
  • Patients with known or suspected mitochondrial disorders caused by mutations in the POLG gene (e.g., Alpers-Huttenlocher Syndrome).
  • Patients with known hypersensitivity to the medicine.

Age-related eligibility rules:

  • Children under 2 years have a considerably higher risk of fatal hepatotoxicity. Use is generally restricted or prohibited in this age group.
  • Safety and effectiveness in children younger than 10 years for certain uses have not been established.

Pregnancy and lactation eligibility status:

  • Pregnancy: The drug is contraindicated for migraine prophylaxis in pregnant women. For other uses, it should generally not be used in women who are pregnant or planning to be pregnant due to the high risk of serious birth defects and decreased IQ in the child.
  • Lactation: The medicine is excreted into human milk, and its use requires careful consideration of the risks to the infant.

Eligibility-related restrictions:

  • The drug carries a Boxed Warning regarding the risk of hepatotoxicity and pancreatitis, which imposes strict conditions and monitoring requirements for its continued use in eligible patients.

Resulting eligibility structure

Official regulatory documents define eligibility by establishing absolute prohibitions for populations with pre-existing conditions—like severe liver disease, urea cycle disorders, or certain genetic disorders—where the risk is unacceptable. For high-risk physiological states, such as pregnancy, the documents impose severe restrictions and mandatory warnings, effectively limiting use to instances where no other suitable treatment is available. This structure dictates who must not use the medicine and who may use it only under tightly controlled and monitored conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Divial, which contains Lorazepam, is characterized by two primary interaction domains: pharmacodynamic reinforcement and pharmacokinetic inhibition.

Pharmacodynamic Interactions

Co-administration with other Central Nervous System (CNS) depressants, including opioids, alcohol, and drugs such as antipsychotics and sedative/hypnotics, results in additive CNS depression. Regulatory documents emphasize the serious risk of profound sedation, respiratory depression, coma, and death when Lorazepam is combined with opioids. The use of Lorazepam with alcohol is explicitly not recommended due to enhanced sedative effects. Additionally, co-use with Clozapine is documented to potentially cause marked sedation and respiratory issues.

Pharmacokinetic and Administration Restrictions

Official labeling identifies Valproate and Probenecid as substances that interfere with Lorazepam's metabolism by inhibiting its clearance through glucuronidation. This pharmacokinetic interaction leads to increased Lorazepam plasma concentrations. Consequently, a formal regulatory requirement mandates a Lorazepam dosage reduction (to approximately 50%) when it is co-administered with either Valproate or Probenecid. Interaction outcomes are noted as potentially more significant in elderly and debilitated patients.

Mechanism of Action

Molecular and Cellular Mechanism

Divial functions as an antagonist of the A1 osteoclast surface receptor. Following systemic action, the active metabolite, M-2, binds to the A1 receptor, which results in the modulation of extbfosteoclastogenesis (the process of new osteoclast formation). The receptor antagonism specifically interrupts the extbfNF-kappa B signaling cascade within the osteoclast cell. This extbfintracellular pathway disruption leads to the decreased expression of key degradative enzymes, notably extbfTRAP (Tartrate-Resistant Acid Phosphatase) and extbfCathepsin K. This mechanistic cascade ultimately restricts the excessive resorption of the bone matrix by mature osteoclasts and influences the structural integrity of the trabecular network. The activity is confined to the biochemical and cellular level, affecting bone remodeling dynamics.

Dosage and Administration Information

Administration and Dosage

Divial (which contains the active ingredient sodium valproate) is an anticonvulsant medication used to manage certain types of seizures, bipolar disorder, and for migraine prophylaxis. It must be taken exactly as prescribed by a healthcare provider. The dosage is highly individualized, starting low and gradually increasing over several days or weeks to achieve optimal clinical effect and minimize side effects.

Oral Administration Guidelines:

  • Tablets/Capsules: Delayed-release and extended-release formulations must be swallowed whole with water. They should not be crushed, broken, or chewed, as this can affect drug release and may cause stomach irritation.
  • With or Without Food: The medication may be taken with or without food, but it is generally advised to maintain consistency (e.g., always taking it with food) to help reduce the potential for stomach upset.
  • Timing: Dosing schedules vary. If taken once daily, establish a consistent time each day. For multiple daily doses (e.g., twice daily), doses should be spaced evenly, often 10 to 12 hours apart, to maintain stable levels in the bloodstream.

Missed Dose:

If a dose is missed, take it as soon as you remember, unless it is nearly time for the next scheduled dose. If it is close to the next dose, skip the missed one and continue with the regular schedule. Never take a double dose to compensate for a missed one. Consistent use is crucial, especially for managing epilepsy, as missed doses can increase the risk of seizures.

Important Considerations:

Do not suddenly stop taking Divial without consulting your healthcare provider, as this can lead to an increase in seizure frequency. Blood tests, including liver function tests, are typically required before and during treatment, particularly during the initial six months, to monitor for potential adverse effects. The therapeutic range of valproate in the blood is often monitored to ensure effective treatment with minimal risk of toxicity.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Divial (Lorazepam)

This section provides a summary of the official research evidence for Divial, detailing the types of studies that have been conducted, the outcomes they measured, and the limitations and uncertainties documented by scientific and regulatory sources.


Evidence for Use in Acute Seizures and Neurological Crises

Research exploring the use of Divial for prolonged, acute seizure episodes primarily consists of Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies monitored patients across all age groups, including Adults, Children, and Infants (from one month of age), who were experiencing seizures requiring urgent stabilization.

Studies monitored outcomes related to the time-sensitive cessation of seizure activity (stoppage) and the need for subsequent rescue medications. The trials monitored outcomes related to the time-sensitive cessation of seizure activity (stoppage) in observed populations. The research also examined study designs where Divial was compared against other medications for acute use.

What remains uncertain is the full extent of the long-term outcomes following these acute episodes. While immediate stability has been extensively studied, data characterizing long-term neurological outcome are not fully established. The evidence quality varies across studies due to differences in how the seizure state was defined and what outcome measures were used.


Evidence for Short-Term Relief of Anxiety Symptoms

The evidence base for using Divial in contexts of pronounced anxiety and tension includes Clinical Trials and Systematic Reviews studying short-term symptom relief. These trials generally included Adults and utilized standardized rating scales to measure changes in symptom intensity.

Studies explored how symptoms evolved in the observed populations, reporting measurements suggesting short-term changes in anxiety scores and reduction in tension. The duration of systematic clinical assessment in these studies has typically been up to approximately four months. There is limited information for long-term outcomes beyond this duration, which has led regulatory bodies to note a research gap.


What Remains Uncertain About the Research Evidence

The research landscape highlights several areas where scientific information is not fully established or remains limited:

  • Long-Term Effectiveness: Systematic data describing the sustained outcomes of Divial when used beyond the short-term periods (four weeks for insomnia, four months for anxiety) are generally unavailable.
  • Monotherapy for Agitation: The evidence exploring Divial's role as a single agent for acute agitation is limited, with many studies reporting patterns based on its use in combination with other medicines.
  • Subgroup Findings: Subgroup findings are uncertain for specific populations defined by comorbidities or severity, outside of the well-studied acute seizure context.

Studies help show what has been observed so far. Research provides context but not individual predictions.

Key Studies & References

  1. Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review (Reviewing combination and monotherapy evidence)
  2. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials
  3. Long-term use of benzodiazepines in chronic insomnia: a European perspective (Discussing duration of use and dependence risks)

Frequently Asked Questions (FAQ)

Common questions about Divial (FAQ)


Q: How quickly should I expect to feel the effects of Divial?

A: Official studies indicate that the maximum concentration of Divial in the bloodstream typically occurs about 2 hours after taking an oral tablet. For anxiety relief, the onset of action may be noticeable sooner, often within 20 to 30 minutes. Individual responses to the drug can vary.


Q: Can Divial be taken on an empty stomach?

A: Regulatory information states that taking Divial with or without food does not significantly change how the body absorbs the medication. To help reduce the potential for stomach upset, consistency in timing relative to meals is generally advised.


Q: Is it normal to experience mild nausea when starting Divial?

A: Nausea has been reported as an uncommon side effect of Divial. Generally, common central nervous system (CNS) effects, like drowsiness, are more likely to occur when treatment begins and may lessen over time. If nausea is persistent or concerning, you should consult with a healthcare provider for guidance.


Q: Does Divial need to be stored in the refrigerator?

A: Storage requirements depend on the specific form of Divial you are using. Tablets must be kept at controlled room temperature (between 20 C and 25 C). However, the oral solution or concentrate usually requires refrigeration (between 2 C and 8 C) and protection from light. Patients should always check the directions on their specific packaging.


Q: Is Divial generally well-tolerated by most people?

A: Regulatory documents indicate that the most common reported side effects are linked to its Central Nervous System (CNS) effects, such as drowsiness and fatigue. Many patients tolerate the medication, but individual response to the drug can vary.


Q: Can Divial affect mood or cause anxiety?

A: While Divial is used to treat anxiety, official labeling reports a risk of rare paradoxical reactions. These can include unexpected effects like increased agitation, hostility, or anxiety. It is also noted that the medication may potentially worsen existing symptoms of depression.


Q: Can Divial be split or crushed for easier swallowing?

A: Patients should follow the specific administration guidelines for their formulation. Delayed-release and extended-release forms must not be crushed or chewed, as this can affect the drug's release. Whether standard tablets can be split depends on their design, and this should be clarified by the prescribing professional.


Q: Is Divial a type of antibiotic or something else?

A: Divial (lorazepam) is not an antibiotic. It is a medication that belongs to the Benzodiazepine pharmacological class. Its purpose is to modulate (slow down) activity in the Central Nervous System (CNS).


Q: Do people typically use Divial long-term or short-term?

A: Official product information emphasizes that Divial is indicated for the short-term relief of anxiety symptoms. Systematic clinical studies have generally not assessed the drug's effectiveness for use longer than four months, leading to limitations on its intended duration of use.


Q: Can Divial be used by children, and if so, at what age?

A: The safety and effectiveness of oral Divial (tablets and oral liquid) have not been established for children under the age of 12 years. Any use in this age group must be carefully considered and guided by a healthcare provider.


Q: Are there any specific dietary restrictions while taking Divial?

A: No specific dietary restrictions are typically mandated for Divial. Official warnings, however, explicitly caution against consuming alcohol while taking this medication due to the serious risk of enhanced sedative effects.


Q: How long does Divial stay in your system after you stop taking it?

A: The time it takes for a medication to be eliminated is often estimated using its half-life. The half-life of lorazepam is approximately 12 hours for the active drug. It usually takes several half-lives for the substance to be fully cleared from the body.


Q: Are there different strengths or formulations of Divial available?

A: Yes, Divial (lorazepam) is supplied in several forms, including oral tablets (commonly 0.5 mg, 1 mg, and 2 mg), an oral solution or concentrate, and an injectable solution. The available strengths vary depending on the specific dosage form.


Q: Is Divial available as a generic drug?

A: Yes, the active ingredient in Divial, lorazepam, is widely available. Regulatory agencies, such as the FDA, have approved generic versions of the product.


Q: What should I do if my symptoms don't improve while using Divial?

A: If symptoms persist or worsen while taking the medication, the continued effectiveness of the drug should be evaluated by a healthcare professional. A periodic reassessment of the drug's usefulness is generally required.


Q: Does Divial cause drowsiness or affect my ability to drive?

A: Divial commonly causes drowsiness and may impair coordination and mental alertness. Official warnings caution that patients should avoid driving or operating dangerous machinery until they understand how the drug affects their coordination and alertness.


Q: Does Divial interact with my existing blood pressure medication?

A: Regulatory documents recommend that patients must disclose all medications to their provider. The primary interaction warning involves additive effects with other Central Nervous System (CNS) depressants, but all prescription medications should be reviewed for potential interactions.


Q: Can Divial cause dry mouth or changes in taste?

A: Both dry mouth and disturbances in taste have been reported as possible side effects associated with the use of Divial. These effects are generally considered less common than the central nervous system side effects.


Q: Is Divial an addictive medication?

A: Official labeling contains a serious warning noting that the use of Divial carries risks of abuse, misuse, and addiction. It is also associated with the development of physical and psychological dependence. The risk of dependence is associated with longer duration of use and higher doses.


Q: Is Divial a controlled substance?

A: Yes, Divial (lorazepam) is formally classified as a Schedule IV controlled substance by the U.S. Drug Enforcement Administration (DEA). This designation means the drug has an accepted medical use but also has a potential for abuse and dependence.


Q: How is Divial metabolized by the body?

A: Lorazepam is primarily metabolized, or broken down, in the liver through a process called glucuronidation. This process converts the active drug into an inactive substance, which is then eliminated from the body, mostly through the urine.


Q: Does Divial have any known interactions with herbal supplements?

A: The official product information strongly advises patients to tell their healthcare provider about all substances, including herbal products and dietary supplements. This is necessary because the combination with certain supplements may lead to serious drug interactions.


Q: What kind of studies have been done on Divial's effectiveness?

A: The effectiveness of Divial has been established through various controlled clinical trials, such as Randomized Controlled Trials, and systematic reviews. These studies assess clinical outcomes like seizure cessation and changes in standardized anxiety rating scales.


Q: Are there any known allergic reactions to the ingredients in Divial?

A: Divial is contraindicated (should not be used) in patients with known hypersensitivity or an allergy to benzodiazepines or any component of its formulation. While rare, serious allergic reactions have been reported in regulatory documents.


Q: Does Divial interact with common foods or beverages like caffeine?

A: The main interaction warning for Divial is with alcohol, which is strictly discouraged due to enhanced sedative effects. Official sources do not indicate known interactions with common foods or beverages like caffeine.


Q: What are the signs that Divial might not be working for a patient?

A: Signs of inadequate therapeutic response would be the persistence of the condition it is intended to treat, such as continued anxiety symptoms or the failure to control acute events. If symptoms remain or worsen, the continued effectiveness of the drug should be evaluated by a healthcare professional.


Q: Can Divial be used in combination with [Name of another drug class]?

A: The official label issues a serious warning against co-administration with other Central Nervous System (CNS) depressants, such as opioids, due to the risk of profound sedation and respiratory depression. Any decision to combine Divial with other drug classes should be guided by a healthcare professional after a full review of potential interactions.

How should Divial be stored and disposed of?

Storage and Disposal of Divial (Lorazepam)

Official storage conditions for Divial vary by dosage form, as mandated by regulatory documents. Divial tablets must be stored at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F), and kept in a tightly closed container. Both the oral solution and the injectable form require refrigeration at 2 C to 8 C (36 F to 46 F) and must be protected from light.

The oral concentrate has a limited in-use shelf life and must be discarded 30 to 90 days after first opening to maintain stability. The injectable solution should be used immediately after dilution. All forms of Divial must be stored out of the sight and reach of children. Unused or expired Divial must be disposed of in accordance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Divial found in:

A-Z Index: